Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

specific

Breakpoint cluster region protein (1271 aa, ~143 kDa) is encoded by the human BCR gene. This protein is involved in both serine/threonine-protein kinase and GTPase-activating protein activities.

Centers

Active Trials

—

Cancer Funding

Top Centers for Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive(14)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	—	53.6
2	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	53.6
3	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	—	53.6
4	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	53.6
5	Hollings Cancer CenterCharleston, SC NCI Clinical	—	—	53.6
6	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	53.6
7	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	53.6
8	University of Illinois Cancer CenterChicago, IL	—	—	53.6
9	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical	—	—	53.6
10	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	—	53.6
11	Cancer Center at IllinoisUrbana, IL	—	—	53.6
12	University of Cincinnati Cancer CenterCincinnati, OH	—	—	53.6
13	Princess Margaret Cancer CentreToronto, ON	—	—	53.6
14	Louisiana Cancer Research CenterNew Orleans, LA	—	—	53.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →